Financial Statements — SNY
Balance Sheet
(in billions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 15.36 | 6.80 | 7.99 | 6.90 | 9.72 |
| Inventory | 9.62 | 10.61 | 9.97 | 9.37 | 9.26 |
| Total Current Assets | 37.02 | -- | -- | -- | -- |
| Goodwill | 40.28 | 50.08 | 49.24 | 50.56 | 44.98 |
| Total Non-current Assets | 87.94 | 99.67 | 95.11 | 93.18 | 82.73 |
| Total Assets | 124.96 | 129.76 | 125.35 | 121.83 | 112.32 |
| Total Current Liabilities | 29.06 | -- | -- | -- | -- |
| Total Non-current Liabilities | 25.62 | 26.73 | 27.61 | 28.45 | 29.81 |
| Total Liabilities* | 54.68 | 56.76 | 52.41 | 50.52 | 48.96 |
| Total Stockholder Equity | 70.28 | 73.00 | 72.95 | 71.30 | 63.36 |
* Derived from reported values
Income Statement
(in billions EUR) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Gross Profit | 15.46 | 15.65 | 15.20 | 14.67 | 12.39 |
| Research & Development | 3.72 | 3.42 | 3.19 | 3.15 | 2.66 |
| Selling, General & Admin | 4.51 | 5.26 | 5.18 | 4.95 | 4.53 |
| Total Operating Expenses* | 11.70 | 12.61 | 10.88 | 10.84 | 8.78 |
| Operating Income | 3.76 | 3.04 | 4.32 | 3.83 | 3.61 |
| Pretax Income* | 6.55 | 2.73 | 4.19 | 3.73 | 3.48 |
| Tax Provision | 0.71 | 0.46 | 0.73 | 0.50 | 0.68 |
| Net Income | 5.84 | 2.26 | 3.46 | 3.24 | 2.80 |
| Basic EPS | -- | -- | -- | 2.55 | 2.22 |
| Diluted EPS | -- | -- | -- | 2.54 | 2.21 |
* Derived from reported values
Cash Flow Statement
(in billions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | 3.56 | 1.42 | 3.56 | 3.83 | 4.75 |
| Investing Cash Flow | 8.73 | (3.41) | (3.07) | (1.46) | (2.34) |
| Financing Cash Flow | (4.49) | 0.09 | (5.21) | (5.60) | (6.62) |
